Alvotech (ALVO)

• Market cap: $2.52B
• 1 day: -0.25%
• 5 days: -6.78%
• 1 month: -18.92%
• 3 months: -36.83%
• 6 months: -38.61%
• Year to date: -40.43%
• 1 year: -45.93%
• 5 years: -29.94%
• 10 years: -29.94%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.

Employees: 1,032

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

260% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 5

43% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 7

41% more funds holding

Funds holding: 32 [Q3] → 45 (+13) [Q4]

12% more capital invested

Capital invested by funds: $178M [Q3] → $200M (+$21.4M) [Q4]

0.07% more ownership

Funds ownership: 5.03% [Q3] → 5.11% (+0.07%) [Q4]

0% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 3 (+0) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $18 130% upside
• Avg. target: $18 130% upside
• High target: $18 130% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

UBS

130% upside $18

Buy Initiated

14 Feb 2025